IL1B and osteoarthritis: The beneficial results of PBA application under inflammatory conditions, such as in rat models of permanent ischemic stroke, osteoarthritis, or acute lung injury models, were shown to decrease the release of pro-inflammatory mediators IL-1β, TNFα, and IL-6 [54–56].